Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By:
Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
4 Small Cap Biotechs With Upcoming Catalysts
Article By:
Scott Matusow
Wednesday, January 10, 2018 7:20 PM EDT
The biotech “run-up” trade has always attracted a wide array of traders looking to take advantage of potentially high alpha price moves before the actual catalyst/binary event come to fruition.
G1 Therapeutics Announces Closing Of Initial Public Offering
Article By:
NASDAQ GlobeNewswire
Tuesday, May 23, 2017 10:14 AM EDT
G1 Therapeutics, Inc., today announced the closing of its initial public offering of 7,781,564 shares of common stock at a public offering price of $15.00 per share.
In this article: GTHX